Ghrelin Down-regulates Proinflammatory Cytokines in Sepsis Through Activation of the Vagus Nerve
- 1 March 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 245 (3), 480-486
- https://doi.org/10.1097/01.sla.0000251614.42290.ed
Abstract
To test the hypothesis that administration of ghrelin attenuates inflammatory responses in sepsis through vagal nerve stimulation. Ghrelin has been demonstrated to possess multiple functions, including stimulation of the vagus nerve. Our recent study has shown that plasma levels of ghrelin were significantly reduced in sepsis; and ghrelin administration improved organ perfusion and function. However, it remained unknown whether ghrelin also decreases proinflammatory cytokines in sepsis and, if so, whether the down-regulatory effect of ghrelin is mediated by activation of the vagus nerve. Male rats were subjected to sepsis by cecal ligation and puncture (CLP). At 5 hours after CLP, a bolus intravenous injection of 2 nmol ghrelin was followed by a continuous infusion of 12 nmol ghrelin via a primed 200-μL Alzet mini-pump for 15 hours. At 20 hours after CLP, plasma and peritoneal fluid levels of TNF-α and IL-6 were determined. The direct effect of ghrelin on cytokine production was studied using cultured normal rat Kupffer cells or peritoneal macrophages stimulated by lipopolysaccharide (LPS). In additional animals, vagotomy or sham vagotomy was performed in sham and septic animals immediately prior to ghrelin administration and cytokine levels were then measured. Ghrelin significantly reduced TNF-α and IL-6 levels in sepsis. In contrast, ghrelin did not inhibit TNF-α and IL-6 release from LPS-stimulated Kupffer cells or peritoneal macrophages. However, vagotomy, but not sham vagotomy, prevented ghrelin's down-regulatory effect on TNF-α and IL-6 production. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Pharmacologic stimulation of the vagus nerve may offer a novel approach of anti-sepsis therapy.Keywords
This publication has 41 references indexed in Scilit:
- Contribution of anti-inflammatory/immune suppressive processes to the pathology of sepsisFrontiers in Bioscience-Landmark, 2006
- Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated ratsJournal of Hepatology, 2005
- Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- GhrelinAnnals of Surgery, 2004
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- Administration of human inter-α-inhibitors maintains hemodynamic stability and improves survival during sepsis*Critical Care Medicine, 2002
- SEMMELWEIS LECTURE SEPSIS RESEARCH: WHAT DID WE DO WRONG? WHAT WOULD SEMMELWEIS DO TODAY?Shock, 2001
- Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): Evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of ratsLife Sciences, 2001
- Central Effects of a Novel Acylated Peptide, Ghrelin, on Growth Hormone Release in RatsBiochemical and Biophysical Research Communications, 2000